TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite <named-content content-type="genus-species">Toxoplasma gondii</named-content>

ABSTRACT New drugs to control infection with the protozoan parasite Toxoplasma gondii are needed as current treatments exert toxic side effects on patients. Approaches to develop novel compounds for drug development include screening of compound libraries and targeted inhibition of essential cellula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Victoria Jeffers, Edwin T. Kamau, Ananth R. Srinivasan, Jonathan Harper, Preethi Sankaran, Sarah E. Post, Joseph M. Varberg, William J. Sullivan, Jon P. Boyle
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://doaj.org/article/b3da351a960c48d3b9fbeae40b5dad3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!